14-3-3 gamma anticorps (AA 1-12)

N° du produit ABIN1818387

Détail du produit anti-14-3-3 gamma anticorps

Antigène: 14-3-3 gamma (YWHAG1)

Épitope: AA 1-12

Reactivité: Humain, Souris, Rat

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp 14-3-3 gamma est non-conjugé

Application: Western Blotting (WB), Immunoprecipitation (IP)

Specificité: Human 14-3-3 Gamma. Antibody has not been tested for cross-reactivity with other forms of 14-3-3.

Purification: Protein A purified

Immunogène: KLH-Human 14-3-3 gammma N-terminal peptide (1-12 a. a.).

Type of Immunogen: Synthetic peptide

Clone: KC21

Isotype: IgG2a

Information d'application

Indications d'application: Approved: IP, WB (0.1 μg/mL)

Usage: IP: 2 μg/100 μg of cell extract from 5x10⁶ cells,

Commentaires:

Target Species of Antibody: Human

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: PBS,  pH 7.2, 50 % glycerol

Stock: -20 °C

Stockage commentaire: Store at -20°C.

Détails sur 14-3-3 gamma

Antigène: 14-3-3 gamma (YWHAG1)

Autre désignation: YWHAG / 14-3-3 gamma (YWHAG1 Produits)

Synonymes: anticorps 14-3-3GAMMA, anticorps YWHAG, anticorps SRCRB4D, anticorps 14-3-3g, anticorps 14-3-3gamma, anticorps ywhag, anticorps 14-3-3G, anticorps D7Bwg1348e, anticorps cb47, anticorps fd20c02, anticorps wu:fd20c02, anticorps wu:fj53d01, anticorps zgc:73131, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma L homeolog, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma, anticorps tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide, anticorps 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide 1, anticorps YWHAG, anticorps ywhag.L, anticorps Ywhag, anticorps ywhag1

Sujet: Name/Gene ID: YWHAG

Synonyms: YWHAG, 14-3-3GAMMA, 14-3-3 gamma, 14-3-3 protein gamma, KCIP-1

ID gène: 7532

Pathways: Myometrial Relaxation and Contraction, M Phase